Learn More
Medchemexpress LLC Inaxaplin (VX-147) | 2446816-88-0 | 99.4% | C21H18F3N3O3 | 10MG

Supplier: Medchemexpress LLC HY13282010MG
Inaxaplin (VX-147) is an orally active small-molecule inhibitor of apolipoprotein L1 (APOL1) channel function, developed for research into APOL1-mediated kidney disease. It is supplied for laboratory research as a high-purity solid or as a DMSO solution.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.